Modeling interleukin-2-based immunotherapy in AIDS pathogenesis
From MaRDI portal
Recommendations
- Immunotherapy of HIV-1 infection
- Infection dynamics in HIV-specific CD4 T cells: does a CD4 T cell boost benefit the host or the virus?
- Analysis of global dynamics for HIV-infection of CD\(4^+\)T cells and its treatment
- HIV-1 POPULATION DYNAMICSIN VIVO: IMPLICATIONS FOR PATHOGENESIS, EFFECT OF CYTOKINE AND THERAPY STRATEGY
- Modeling CD4\(^+\) T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7
Cites work
- A model of HIV-1 pathogenesis that includes an intracellular delay
- A model of primary HIV-1 infection
- CXCR4 and CCR5 regulation and expression patterns on T- and monocyte--macrophage cell lineages: Implications for susceptibility to infection by HIV-1
- Drug concentration heterogeneity facilitates the evolution of drug resistance
- Dynamics of HIV infection of CD4^ + T cells
- Evolutionary game theoretic strategy for optimal drug delivery to influence selection pressure in treatment of HIV-1
- Host immune responses that promote initial HIV spread
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- The MATLAB ODE Suite
Cited in
(7)- Modeling the role of IL-2 in the interplay between CD4+ helper and regulatory T cells: assessing general dynamical properties
- Modeling CD4\(^+\) T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7
- On \(T\)-cell dynamics and the hyperactivation theory of AIDS pathogenesis
- Controlling IL-7 injections in HIV-infected patients
- Immunotherapy of HIV-1 infection
- T cell and reticular network co-dependence in HIV infection
- scientific article; zbMATH DE number 5284012 (Why is no real title available?)
This page was built for publication: Modeling interleukin-2-based immunotherapy in AIDS pathogenesis
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1790721)
